Skip to main content
. 2019 Dec 16;19:352. doi: 10.1186/s12877-019-1361-2

Table 2.

Associations between liver enzyme elevation and various demographic and clinical variables

Characteristics Presence of liver enzyme elevation P value Odds ratio (95% CI)
Yes No
(n = 24, 4.7%) (n = 491, 95.3%)
Age (years) 82.6 ± 3.8a 83.9 ± 3.4a
 80 ≃ 85 19(3.7%)b 308(59.8%) 1.000
 85 ≃ 90 3(0.6%) 149(28.9%) 0.075 0.326(0.095, 1.120)
  ≥ 90 2(0.4%) 34(6.6%) 0.950 0.954(0.213, 4.271)
Sex
 Male 20(3.9%) 390(75.7%) 1.000
 Female 4(0.8%) 101(19.6%) 0.644 0.772(0.258, 2.310)
Hepatitis B
 No 16(3.1%) 477(92.6%) 1.000
 Yes 8(1.6%) 14(2.7%) < 0.001 17.036(6.259, 46.371)
Fatty liver
 No 16(3.1%) 450(87.4%) 1.000
 Yes 8(1.6%) 41(8.0%) 0.009 3.659(1.376, 9.726)
Biliary calculus
 No 16(3.1%) 411(79.8%) 1.000
 Yes 8(1.6%) 80(15.5%) 0.036 2.570(1.064, 6.206)
Other diseases
  ≤ 2 1(0.2%) 30(5.8%) 1.000
 3 ≃ 5 9(1.7%) 203(39.4%) 0.790 1.330(0.163, 10.875)
  ≥ 5 14(2.7%) 258(50.1%) 0.644 1.628(0.207, 12.820)
Other drugs
  < 5 5(1.0%) 94(18.3%) 1.000
 5 ≃ 10 16(3.1%) 352(68.3%) 0.765 0.855(0.305, 2.393)
  ≥ 10 3(0.6%) 45(8.7%) 0.764 1.253(0.287, 5.477)
Drinking habits
 No drinking 8(1.6%) 483(93.8%) 1.000
 Mild to moderate 11(2.1%) 3(0.6%) 0.425 1.585(0.511, 4.914)
 Heavy 5(1.0%) 5(1.0%) < 0.001 27.733(7.245,106.164)
Statin variety
 Simvastatin 6(1.2%) 92(17.5%) 1.000
 Fluvastatin 8(1.6%) 108(21.0%) 0.820 1.136(0.380, 3.393)
 Pravastatin 4(0.8%) 76(14.8%) 0.747 0.807(0.220, 2.964)
 Rosuvastatin 1(0.2%) 84(16.3%) 0.119 0.183(0.022, 1.548)
 Atorvastatin 5(1.0%) 131(25.4%) 0.388 0.585(0.173, 1.975)
Statin dose
 Low 4(0.8%) 66(12.8%) 1.000
 Standard 20(3.9%) 425(82.5%) 0.653 0.776(0.257, 2.342)

adata are expressed as mean ± SD. ball percentages in the table are of the total samples (n = 515)